Continue with FacebookLooking to list your PhD opportunities? Log in here.
We have 11 monoclonal antibodies PhD Projects, Programmes & Scholarships PhD Projects, Programmes & Scholarships
monoclonal antibodies PhD Projects, Programmes & Scholarships PhD Projects, Programmes & Scholarships
We have 11 monoclonal antibodies PhD Projects, Programmes & Scholarships PhD Projects, Programmes & Scholarships
PhD saved successfully
Selection and evaluation of new universal influenza vaccine candidates using monoclonal antibodies and digitally designed HA and NA libraries & pseudotype virus screens
Universal influenza vaccines are a major global R&D vaccine priority. The Temperton (ORCID. https://orcid.org/0000-0002-7978-3815). Read more
Selection and evaluation of new universal influenza vaccine candidates using monoclonal antibodies and digitally designed HA and NA libraries & pseudotype virus screens
Universal influenza vaccines are a major global R&D vaccine priority. The Temperton (ORCID. https://orcid.org/0000-0002-7978-3815). Read more
Chemical glycoengineering of therapeutic antibodies
Glycosylation is the most common posttranslational protein modification. Recombinant therapeutic glycoproteins (RTGs) such as monoclonal antibodies (mAbs) are decorated with complex glycans that determine not only their efficacy but also other critical parameters such as in vivo half-life, stability and antigenicity. Read more
Generation of human cytomegalovirus-pseudotyped particles and development of systems for the study of viral cell entry mechanisms, neutralizing antibody responses to infection and vaccination, and testing of potential novel therapeutics
Overview. Human cytomegalovirus (HCMV) establishes lifelong infections of the host with >60% infected across the globe. In healthy children and adults HCMV produces mild symptoms like influenza or mononucleosis. Read more
Generation of human cytomegalovirus-pseudotyped particles and development of systems for the study of viral cell entry mechanisms, neutralizing antibody responses to infection and vaccination, and testing of potential novel therapeutics
Overview. Human cytomegalovirus (HCMV) establishes lifelong infections of the host with >60% infected across the globe. In healthy children and adults HCMV produces mild symptoms like influenza or mononucleosis. Read more
The Creation of Anti-Viral Plastic Nanobodies for Diagnostics and Therapeutics via Molecular Imprinting of Synthetic Polymers
Overview. The need to quickly generate new diagnostic tools and therapies in the battle against viral diseases has been highlighted recently by the continuing global pandemic caused by the SARS-CoV-2 virus. Read more
The Creation of Anti-Viral Plastic Nanobodies for Diagnostics and Therapeutics via Molecular Imprinting of Synthetic Polymers
Overview. The need to quickly generate new diagnostic tools and therapies in the battle against viral diseases has been highlighted recently by the continuing global pandemic caused by the SARS-CoV-2 virus. Read more
Last chance to apply
Analysis of Oligonucleotide Therapeutics Using 2D Liquid Chromatography
We invite applications for a three and a half-year industry funded PhD studentship to work under the supervision of Prof Mark Dickman at the University of Sheffield in collaboration Dr Christina Vanhinsbergh (AstraZeneca) and Dr Ken Cook (ThermoFisher). Read more
Hypoxia and HIF signalling in TME as regulators of pro- and anti- tumour-associated immune cell functions (ref: SF22/HLS/APP/GIELING)
Hypoxia (low oxygen tension) and hypoxia-inducible factor (HIF)-1 and HIF-2 signalling are environmental cues on the immune system in both acute and chronic human diseases. Read more
Understanding the Stability of Biologics Using Advanced Light Scattering Techniques
The biotherapeutics market was valued at approximately USD 325.17 billion in 2020. It is expected to witness a revenue of USD 496.71 billion in 2026, with a CAGR of 7.32% over the forecast period, 2021-2026. Read more
Biological significance, predictive value and targeting of cell surface antigens in colorectal cancer.
Despite major advances in its early detection, preventive measures and therapeutic options, colorectal cancer is the fourth most commonly diagnosed cancer and the third leading cause of cancer deaths worldwide. Read more
- 1